Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccineChangrui Lu, Xiaoming Yang|Antiviral Research|2023Cited by 10
In Silico and In Vitro Studies of 4-Hydroxycoumarin-Based Heterocyclic Enamines as Potential Anti-Tumor AgentsMediha Assad, Changrui Lu, Abu Bakar Siddique et al.|Molecules|2023Cited by 3
Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccineChangrui Lu, Xiaoming Yang|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1